drugset / Trial / NCT02152969

Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)

NCT02152969

Phase 1 Completed 66 enrolled Yuhan Corporation
RandomizedCrossoverOpen-labelBasic science

Summary

To evaluate Drug-drug interaction

Timeline

Start
2014-05
Primary completion
2014-08
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified
Subject Chlorthalidone Other / unclassified
Subject Telmisartan Other / unclassified

Indications